129 related articles for article (PubMed ID: 36510977)
1. Impact of radical dose escalation by endoluminal brachytherapy and induction chemotherapy in the definitive treatment of locally advanced esophageal cancer - A retrospective study.
Raghunath S; Tiwari R; Rashmi S; Geetha SN; Sulthana R; Madabhavi I
J Cancer Res Ther; 2022 Dec; 18(Supplement):S280-S284. PubMed ID: 36510977
[TBL] [Abstract][Full Text] [Related]
2. Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus: mature results of a phase I/II trial.
Pöttgen C; Gkika E; Stahl M; Abu Jawad J; Gauler T; Kasper S; Trarbach T; Herrmann K; Lehmann N; Jöckel KH; Lax H; Stuschke M
Radiat Oncol; 2021 Mar; 16(1):59. PubMed ID: 33757534
[TBL] [Abstract][Full Text] [Related]
3. Concomitant chemotherapy and external radiotherapy plus brachytherapy for locally advanced esophageal cancer: results of a retrospective multicenter study.
Tessa M; Rotta P; Ragona R; Sola B; Grassini M; Nassisi D; Sciacero P; Airoldi M; Filippi A; Gianello L; De Angelis C; Ozzello F; Trotti AB; Ricardi U; Sannazzari GL
Tumori; 2005; 91(5):406-14. PubMed ID: 16459637
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus.
Gkika E; Gauler T; Eberhardt W; Stahl M; Stuschke M; Pöttgen C
Dis Esophagus; 2014; 27(7):678-84. PubMed ID: 24147973
[TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and midthoracic esophagus.
Stuschke M; Stahl M; Wilke H; Walz M; Oldenburg A; Stüben G; Seeber S; Sack H
Am J Clin Oncol; 2000 Jun; 23(3):233-8. PubMed ID: 10857883
[TBL] [Abstract][Full Text] [Related]
6. Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center.
Bhatt L; Tirmazy S; Sothi S
Dis Esophagus; 2013 Jan; 26(1):57-60. PubMed ID: 22404484
[TBL] [Abstract][Full Text] [Related]
7. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer.
Sur RK; Donde B; Levin VC; Mannell A
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):447-53. PubMed ID: 9457834
[TBL] [Abstract][Full Text] [Related]
8. [Simultaneous radiochemotherapy and endoluminal HDR brachytherapy in esophageal cancer].
Patonay P; Naszály A; Mayer A
Strahlenther Onkol; 2007 Feb; 183(2):94-8. PubMed ID: 17294114
[TBL] [Abstract][Full Text] [Related]
9. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
[TBL] [Abstract][Full Text] [Related]
10. Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207).
Gaspar LE; Winter K; Kocha WI; Pinover WH; Herskovic ; Graham M; Gunderson L
Cancer J; 2001; 7(5):388-94. PubMed ID: 11693897
[TBL] [Abstract][Full Text] [Related]
11. A phase I/II study of CHARTWEL with concurrent chemotherapy in locally advanced, inoperable carcinoma of the oesophagus.
Harney J; Goodchild K; Phillips H; Glynne-Jones R; Hoskin PJ; Saunders MI
Clin Oncol (R Coll Radiol); 2003 May; 15(3):109-14. PubMed ID: 12801046
[TBL] [Abstract][Full Text] [Related]
12. Endoluminal high-dose-rate brachytherapy for locally recurrent or persistent esophageal cancer.
Taggar AS; Pitter KL; Cohen GN; Schattner M; Gerdes H; Markowitz AJ; Ilson D; Brady P; Cuaron JJ; Goodman KA; Wu AJ
Brachytherapy; 2018; 17(3):621-627. PubMed ID: 29496425
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stages IIB and III esophageal carcinoma: results of a pilot study.
Calais G; Dorval E; Louisot P; Bourlier P; Klein V; Chapet S; Reynaud-Bougnoux A; Huten N; De Calan L; Aget H; Le Floch O
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):769-75. PubMed ID: 9240645
[TBL] [Abstract][Full Text] [Related]
14. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study.
Strauss HG; Kuhnt T; Laban C; Puschmann D; Pigorsch S; Dunst J; Koelbl H; Haensgen G
Strahlenther Onkol; 2002 Jul; 178(7):378-85. PubMed ID: 12163992
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study of external beam radiation, neutron brachytherapy, and concurrent chemotherapy for patients with localized advanced carcinoma of the esophagus.
Ma K; Wang Q; Li T; Liu H; Liu B; Jia X; Li S; Lang J; Zhang M
Radiat Oncol; 2014 Dec; 9():294. PubMed ID: 25515326
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
[TBL] [Abstract][Full Text] [Related]
17. A prospective comparative study between concurrent chemoradiation with brachytherapy boost with concurrent chemoradiation alone in locally advanced cancer esophagus.
Tudu R
South Asian J Cancer; 2020; 9(1):20-22. PubMed ID: 31956613
[TBL] [Abstract][Full Text] [Related]
18. Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency.
Rosenblatt E; Abdel-Wahab M; El-Gantiry M; Elattar I; Bourque JM; Afiane M; Benjaafar N; Abubaker S; Chansilpa Y; Vikram B; Levendag P
Radiat Oncol; 2014 Mar; 9():67. PubMed ID: 24581393
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of concomitant chemoradiation versus concomitant chemoradiation followed by high-dose-rate intraluminal brachytherapy in locally advanced esophageal carcinoma: a single institutional study.
Halder A; Biswas R; Ghosh A; Dastidar AG
J Contemp Brachytherapy; 2018 Jun; 10(3):225-231. PubMed ID: 30038642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
